UK biotech using AI to discover drug targets for cardiovascular diseases.
Funding history
Date
Round
Amount
Jul 2022
Pre Seed
Cambridge biotech CardiaTec raised a 1.4M pound (1.6M euro) pre-seed led by Laidlaw Scholars Ventures and APEX Ventures to develop AI-driven cardiovascular drug discovery.